ClinicalTrials.gg
CompletedNCT06821412Updated Nov 4, 2025Results posted

Wireless Prosthetic Control Effectiveness Study

An interventional study of ASTERISK System and Wired Configuration in Prostheses and Upper Limb Amputation Below Elbow, sponsored by Liberating Technologies, Inc.. Completed at 1 site in United States. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2025-11-04.

Sponsored by Liberating Technologies, Inc. · Not applicable, Interventional, and Device feasibility

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Jun 2024, registered Jan 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
4
Allocation
Randomized
Ages
18 Years to 89 Years
Sex
All
01

Study summary

The goal of this proposed project is to evaluate the effectiveness of our novel wireless electrode system, which the investigators refer to as the Asterisk system, on transradial prosthesis users. There are numerous benefits to the upper limb prosthesis community being able to utilize wireless electrodes. These benefits include allowing for the use of a prosthetics liner to assist with fit and comfort, easier implementation of electromyography (EMG) controlled (also referred to as myoelectric control) prosthesis for individuals with osseointegration, and additional EMG electrode location options if the muscle activity captured within the prosthetic socket does not provide reliable prosthesis control. The investigators intend to use this data to develop the Asterisk wireless electrode system into a commercial product. The findings will also be shared with the research community to help drive the design of future devices.

Read the detailed description

The study evaluates the Asterisk system to determine if Asterisk will increase a user's self-reported satisfaction with their prosthesis as measured by the Orthotic and Prosthetic User Survey-Satisfaction with Device (OPUS-SD) when compared to their current prosthesis. While the technology has the potential to benefit other patient populations, the investigators will focus this initial pilot study on individuals with trans-radial limb absence to reduce potential confounding variables associated with including other amputation levels.

The proposed Asterisk system would allow for liners to be worn with upper limb myoelectric systems. By creating wireless sensors that can be worn under a liner, the sensors can be placed on the skin to collect the myoelectric signal, the liner then rolled over the top of the sensors when donning, and the sensors can transmit the EMG signal wirelessly to the prosthesis. The Asterisk system would also be beneficial to those with osseointegration, unreliable prosthesis control with EMG signals collected in the area encompassed by their socket, and prosthesis users who struggle with volume management.

The investigators plan to conduct a randomized 2x2 crossover study to evaluate benefits provided by prostheses utilizing the Asterisk electrodes over standard prostheses. The two crossover test conditions are "Experimental" (myoelectric control with the Asterisk system) and "Control" (standard prosthetic device configuration). For the control condition, the subject will be using their everyday prosthesis. For the experimental condition, the investigators will fabricate and provide a new socket to allow for the additional socket volume necessary for liners worn with the Asterisk electrodes. Each subject will participate in both conditions of the study. The condition that each subject completes first will be chosen by a random number generator that also ensures block randomization with an equal number of participants assigned to each condition first in the test sequence using a custom program that was created under a prior research project.

Subjects will participate in at least four research visits and will take part in two, one-month long take-home periods. Some researchers have suggested that persons with transradial amputation require, on average, 3-5 weeks of training , while others have suggested that 5 hours of training is sufficient . Therefore, the investigators expect a one-month take-home period to be sufficient to allow users to become comfortable with each socket configuration while optimizing the take-home duration to maximize study efficiency.

In-lab test visits will consist of outcome measures such as the OPUS-SD and the Box and Blocks functional test for each study condition.

After receiving IRB approval, subjects will be recruited and screened for eligibility. If they are eligible and decide to participate, they will be scheduled for their first site visit. At the first study visit, subjects will be given the informed consent form to read through entirely before signing and are encouraged to ask questions at any time.

All subjects, regardless of test condition, will then receive training on controlling their prosthesis in their current test condition by the study personnel. The training will start with basic skills, including opening and closing the device, and grasping various shapes such as cone/cups, regular/irregular block shapes, and various size and weight balls. Then they will advance to splinter skills, involving partial completion of activities of daily living (ADL) tasks, for example, positioning the device on the handle of a large mug and gripping the handle. And finally, they will practice full task skills, e.g., grasping the handle of a large mug and bringing the mug up to the subject's mouth to drink from it, putting the mug back down, and releasing the grip. All subjects will also receive instructions on how to fill out the daily log (for the ensuing at-home portion of the study).

In certain cases, subjects may become too fatigued (physically or mentally) to complete the entire planned activity during the scheduled visit. Additionally, in some cases, equipment failures may delay completion of the activity planned for a visit. In such a case, subjects may be invited to return to complete the visit activity at the next mutually agreed date. If the return visit is due to equipment failures, subjects will be offered the standard travel stipend for the secondary visit.

During take-home periods, the investigators will periodically check-in with the subject (by phone, text, email, etc.) to maximize adherence to the daily log, debug any technical issues, etc.

02

Conditions studied

  • Prostheses
  • Upper Limb Amputation Below Elbow
03

In context

Lead sponsor

Liberating Technologies, Inc. is the lead sponsor of 15 studies on the registry; 4 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 5 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • current wearers of trans-radial myoelectric prostheses or orthoses
  • have used their prostheses/orthoses for at least six months
  • understand spoken and written English (for the purpose of consenting)

Exclusion criteria

Exclusion Criteria:

  • have any neurological or physical conditions which would prevent them from performing the experimental tasks
  • are pregnant
05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
4 participants (actual)

Study arms

  • Experimental
    Wireless Control

    The participant wears the experimental socket in the wireless configuration using the prototype ASTERISK system connected within the electronics of the prosthetic socket. The electronics are not accessible by the participant which allows both configurations to be blinded to the participants.

    Device: ASTERISK System

  • Sham comparator
    Wired Control

    The participant wears the experimental socket in the wired configuration, which mimics the current setup for EMG-controlled prostheses. The electronics are not accessible by the participant which allows both configurations to be blinded to the participants.

    Device: Wired Configuration

Interventions

  • DeviceASTERISK System

    This intervention uses an experimental socket fabricated by a certified prosthetist. The electronics within the experimental socket are set up with the ASTERISK system, which sends information collected from the EMG sensors to the prosthetic hand wirelessly rather than the current available method of wired control.

  • DeviceWired Configuration

    This intervention uses the same experimental socket that is used for the ASTERISK intervention. The prosthesis is set-up with wired EMG control, which is the current available method for EMG-controlled prostheses.

06

What researchers measure

Primary outcomes

  1. Orthotics and Prosthetics User Survey - Satisfaction With Device (OPUS-SD)

    The Orthotics and Prosthetics User's Survey (OPUS) is a self-report questionnaire consisting of five modules. The version of the OPUS which will be administered consists of 9 questions in 1 category (satisfaction with device). Questions are asked and scored on a scale from 0-4 (0=strongly disagree, 1=disagree, 2=neither agree nor disagree, 3=agree, and 4=strongly agree), with a higher value indicating a better outcome. There is an additional response for "Don't know / Not Applicable", which if chosen, is not included in the scoring. This survey will be given at the end of each study condition (2 conditions, 1 month per condition). Analysis is reported as a value that calculates the average of all questions (sum up all questions and divide by total number of questions).

    Time frame: At the end of each 1 month condition

07

Results

Posted Nov 4, 2025

Participant flow

Participant flow — Overall Study
MilestoneWireless Control, Then Wired ControlWired Control, Then Wireless Control
Started31
Completed31
Not completed00

Outcome measures

PrimaryOrthotics and Prosthetics User Survey - Satisfaction With Device (OPUS-SD)

The Orthotics and Prosthetics User's Survey (OPUS) is a self-report questionnaire consisting of five modules. The version of the OPUS which will be administered consists of 9 questions in 1 category (satisfaction with device). Questions are asked and scored on a scale from 0-4 (0=strongly disagree, 1=disagree, 2=neither agree nor disagree, 3=agree, and 4=strongly agree), with a higher value indicating a better outcome. There is an additional response for "Don't know / Not Applicable", which if chosen, is not included in the scoring. This survey will be given at the end of each study condition (2 conditions, 1 month per condition). Analysis is reported as a value that calculates the average of all questions (sum up all questions and divide by total number of questions).

Time frame:
At the end of each 1 month condition
Reported as:
Mean · score on a scale
Orthotics and Prosthetics User Survey - Satisfaction With Device (OPUS-SD)
score on a scaleWireless ControlWired Control
Orthotics and Prosthetics User Survey - Satisfaction With Device (OPUS-SD)2.89 ± 0.943.11 ± 0.77

Adverse events

Collected over Adverse events were monitored/collected during each condition. With each condition lasting about 1 month, each participant was monitored for adverse events for about 3 months total. Adverse events were monitored/assessed as needed, with study staff checking in more frequently if participants reached out with questions. Participants were told to reach out to study staff immediately if adverse events did occur.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Wireless Control0/4 (0%)0/4 (0%)0/4 (0%)
Wired Control0/4 (0%)0/4 (0%)0/4 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Wireless Control, Then Wired ControlWired Control, Then Wireless ControlTotal
<=18 years000
Between 18 and 65 years213
>=65 years101
Sex: Female, Male
Sex: Female, Male(Participants)Wireless Control, Then Wired ControlWired Control, Then Wireless ControlTotal
Female202
Male112
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Wireless Control, Then Wired ControlWired Control, Then Wireless ControlTotal
Hispanic or Latino000
Not Hispanic or Latino314
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Wireless Control, Then Wired ControlWired Control, Then Wireless ControlTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American000
White314
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)Wireless Control, Then Wired ControlWired Control, Then Wireless ControlTotal
United States314
08

Study locations

1 site
  • Liberating Technologies, Inc.
    Holliston, Massachusetts 01746, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2024 to primary completion in Jun 2025, 11 months.

Results were first posted in Nov 2025, 4 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 17, 2025
First posted
Feb 12, 2025
StartActual
Jun 13, 2024
Primary completionActual
Jun 12, 2025
CompletionActual
Jun 12, 2025
Results first posted
Nov 4, 2025
Last update
Nov 4, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06821412
Lead sponsor
Liberating Technologies, Inc.
Collaborators
University of Hartford, Worcestor Polytechnic Institute (WPI)
Responsible party
Sponsor
First posted
Feb 12, 2025
Start date
Jun 13, 2024
Primary completion
Jun 12, 2025
Completion
Jun 12, 2025
Results posted
Nov 4, 2025
Last update
Nov 4, 2025

Study contacts

Benjamin McDonald
principal investigator · Liberating Technologies, Inc.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion